Literature DB >> 17514409

Impact of splenectomy in patients with gastric adenocarcinoma of the cardia.

Chikara Kunisaki1, Hirochika Makino, Hirokazu Suwa, Tsutomu Sato, Takashi Oshima, Yasuhiko Nagano, Syoichi Fujii, Hirotoshi Akiyama, Masato Nomura, Yuichi Otsuka, Hidetaka A Ono, Takashi Kosaka, Ryo Takagawa, Yasushi Ichikawa, Hiroshi Shimada.   

Abstract

Previous reports have suggested that splenectomy treatment of gastric carcinoma of the cardia results in poor patient outcome, but the reason for this is unclear. This study aimed to clarify the impact of splenectomy for gastric carcinoma patients. A total of 118 patients with gastric carcinoma of the cardia were enrolled in this study. The characteristics of patients with lymph node metastasis at the splenic hilum were determined, and the effects of lymph node dissection or splenectomy on postoperative morbidity, mortality, and pattern of recurrence were evaluated. Advanced tumors were common in patients with lymph node metastasis at the splenic hilum, Siewert type III, greater curvature sites, larger and deeper tumors, multiple metastatic lymph nodes, and high incidences of para-aortic lymph node metastasis frequently observed. The effectiveness of lymph node dissection of the splenic hilum was low and equal to that of dissection of the para-aortic lymph nodes. Postoperative morbidity, as represented by pancreatic fistula, was high following splenectomy or pancreaticosplenectomy, but patient mortality did not occur. Hematogenous metastasis was common, as well as peritoneal metastasis after curative gastrectomy. Splenectomy should be limited in those patients with gastric cardia tumors invading the spleen or with metastatic bulky lymph nodes extending to the spleen.

Entities:  

Mesh:

Year:  2007        PMID: 17514409     DOI: 10.1007/s11605-007-0186-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

1.  End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma.

Authors:  E Otsuji; T Yamaguchi; K Sawai; M Ohara; T Takahashi
Journal:  Surgery       Date:  1996-07       Impact factor: 3.982

2.  Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients.

Authors:  Roberto Biffi; Antonio Chiappa; Fabrizio Luca; Simonetta Pozzi; Felice Lo Faso; Sabine Cenciarelli; Bruno Andreoni
Journal:  J Surg Oncol       Date:  2006-04-01       Impact factor: 3.454

3.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

4.  Role of lymph node dissection and splenectomy in node-positive gastric carcinoma.

Authors:  Y Adachi; T Kamakura; M Mori; Y Maehara; K Sugimachi
Journal:  Surgery       Date:  1994-11       Impact factor: 3.982

5.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

6.  Comparison of results of surgery in the upper third and more distal stomach.

Authors:  Chikara Kunisaki; Hiroshi Shimada; Hidetaka Andrew Ono; Yuichi Otsuka; Goro Matsuda; Masato Nomura; Hirotoshi Akiyama
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

7.  A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma.

Authors:  Attila Csendes; Patricio Burdiles; Jorge Rojas; Italo Braghetto; Juan Carlos Diaz; Fernando Maluenda
Journal:  Surgery       Date:  2002-04       Impact factor: 3.982

8.  Implication of extended lymph node dissection stratified for advanced gastric cancer.

Authors:  Chikara Kunisaki; Hiroshi Shimada; Masazumi Takahashi; Masato Nomura; Goro Matsuda; Yuichi Otsuka; Hidetaka Ono; Hirotoshi Akiyama
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

9.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

10.  Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer.

Authors:  Jürgen Weitz; David P Jaques; Murray Brennan; Martin Karpeh
Journal:  Ann Surg Oncol       Date:  2004-07       Impact factor: 5.344

View more
  24 in total

1.  Prognostic factors for patients after curative resection for proximal gastric cancer.

Authors:  Donghui Zhao; Huimian Xu; Kai Li; Zhe Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes.

Authors:  Kohei Nakata; Eishi Nagai; Kenoki Ohuchida; Shuji Shimizu; Masao Tanaka
Journal:  Surg Endosc       Date:  2014-10-16       Impact factor: 4.584

3.  Role of splenectomy in proximal gastric cancer patients undergoing total gastrectomy.

Authors:  Jun-Te Hsu; Ta-Sen Yeh; Yi-Yin Jan
Journal:  Transl Gastroenterol Hepatol       Date:  2016-11-23

4.  Lymph node metastasis in gastric cardiac adenocarcinoma in male patients.

Authors:  Gang Ren; Ying-Wei Chen; Rong Cai; Wen-Jie Zhang; Xiang-Ru Wu; Ye-Ning Jin
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

5.  Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis.

Authors:  Kun Yang; Xin-Zu Chen; Jian-Kun Hu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

6.  [Distal pancreatectomy: radical or spleen-preserving?].

Authors:  A M Chromik; M Janot; D Sülberg; M H Seelig; W Uhl
Journal:  Chirurg       Date:  2008-12       Impact factor: 0.955

7.  Laparoscopic spleen-preserving splenic hilar lymphadenectomy in 108 consecutive patients with upper gastric cancer.

Authors:  Ping Li; Chang-Ming Huang; Chao-Hui Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Yi Wang; Qi-Yue Chen
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Gastrectomy and lymphadenectomy for gastric cancer: is the pancreas safe?

Authors:  Fernando A Herbella; Ana C Tineli; Jorge L Wilson; Jose C Del Grande
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

9.  Surgical treatment of gastric cancer in a community hospital in Brazil: who are we treating and how?

Authors:  Rachid Nagem; Lila G M F Bicalho; Laércio G Lourenço
Journal:  J Gastrointest Cancer       Date:  2013-12

10.  Is Splenic Hilar Lymph Node Dissection Without Splenectomy Essential for Proximal Advanced Gastric Cancer?

Authors:  Yoon Jung Oh; Deok Hee Kim; Bang Wool Eom; Hong Man Yoon; Young-Woo Kim; Keun Won Ryu
Journal:  Ann Surg Oncol       Date:  2021-07-17       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.